Harresh Dulamal
Family Medicine · Savannah, GANPI 1699773457
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 213 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 35 manufacturers, the largest accounting for just 19.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $977 and has fallen 97.7% since, to $22 in 2023.
Across 213 payments — averaging $15.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$625
- AstraZeneca$454
- Pfizer$397
- Boehringer Ingelheim$213
- Amarin Pharma, Inc.$206
- Amgen$202
- plus $1K from 29 others
What the payments were for
- Food & beverage$3,287100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 42 | $625 |
| AstraZeneca | 31 | $454 |
| Pfizer | 26 | $397 |
| Boehringer Ingelheim | 14 | $213 |
| Amarin Pharma, Inc. | 10 | $206 |
| Amgen(2 entities) | 13 | $202 |
| Astellas Pharma US Inc | 11 | $183 |
| Lilly USA, LLC | 8 | $109 |
| Kowa Pharmaceuticals America, Inc. | 8 | $106 |
| AbbVie | 7 | $100 |
| Sanofi-aventis U.S. LLC | 5 | $79 |
| Novartis | 4 | $63 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $57 |
| Boston Scientific | 3 | $55 |
| Esperion Therapeutics, Inc. | 3 | $53 |
| Merck | 3 | $51 |
| Genentech USA, Inc. | 3 | $50 |
| Teva Pharmaceuticals USA, Inc. | 2 | $27 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $20 |
| Hologic Sales And Service, LLC | 1 | $19 |
| Idorsia Pharmaceuticals US Inc | 1 | $19 |
| Bayer | 1 | $17 |
| Lifescan, Inc. | 1 | $16 |
| Johnson & Johnson | 1 | $15 |
| Arbor Pharmaceuticals, Inc. | 1 | $14 |
| Shield Therapeutics Inc | 1 | $14 |
| Eisai Inc. | 1 | $14 |
| Sanofi Pasteur Inc. | 1 | $14 |
| Hikma Pharmaceuticals USA | 1 | $13 |
| Paratek Pharmaceuticals, Inc. | 1 | $13 |
| IBSA Pharma Inc. | 1 | $12 |
| GSK | 1 | $12 |
| Aytu Biopharma, Inc. | 1 | $12 |
| Endo Pharmaceuticals Inc. | 1 | $12 |
How this compares
$3,287 in reported general payments places this provider in the 75th percentile of 3,111 family medicine providers in Georgia.
Other family medicine in Savannah
- Debbie HaginsSavannah$279K
- Jeffrey KingsleyColumbus$404K
- Yolanda WadeTyrone$233K
- Julian HutchinsWarrenton$222K
- Nadine Halliburton-FosterCumming$219K
- Contessa MetcalfeAtlanta$157K
- Elmore AlexanderStone Mountain$155K
- Bantwal BaligaColumbus$115K
- Avril CampbellFort Benning$108K
- Mitzi RubinMarietta$103K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.